Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Peroxisome proliferator-activated receptors in inflammation control.

Delerive P, Fruchart JC, Staels B.

J Endocrinol. 2001 Jun;169(3):453-9. Review.

2.

[Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].

Bocher V, Chinetti G, Fruchart JC, Staels B.

J Soc Biol. 2002;196(1):47-52. Review. French.

PMID:
12134632
3.

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.

Chinetti G, Fruchart JC, Staels B.

Z Kardiol. 2001;90 Suppl 3:125-32. Review.

PMID:
11374025
4.

Peroxisome proliferator-activated receptors and the control of inflammation.

Cabrero A, Laguna JC, Vázquez M.

Curr Drug Targets Inflamm Allergy. 2002 Sep;1(3):243-8. Review.

PMID:
14561188
5.
6.

PPARS in inflammation, atherosclerosis and thrombosis.

Duez H, Fruchart JC, Staels B.

J Cardiovasc Risk. 2001 Aug;8(4):187-94. Review.

PMID:
11550996
7.

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.

Barbier O, Torra IP, Duguay Y, Blanquart C, Fruchart JC, Glineur C, Staels B.

Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):717-26. Review.

8.

Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.

Sertznig P, Seifert M, Tilgen W, Reichrath J.

Am J Clin Dermatol. 2008;9(1):15-31. Review.

PMID:
18092840
9.
10.

Peroxisome proliferator-activated receptors and the regulation of mammalian lipid metabolism.

Smith SA.

Biochem Soc Trans. 2002 Nov;30(Pt 6):1086-90. Review.

PMID:
12440979
11.
12.

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.

Marx N, Duez H, Fruchart JC, Staels B.

Circ Res. 2004 May 14;94(9):1168-78. Review.

13.

Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation.

Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C.

J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):267-73. Review.

PMID:
12943712
14.

Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis.

Neve BP, Fruchart JC, Staels B.

Biochem Pharmacol. 2000 Oct 15;60(8):1245-50. Review.

PMID:
11007963
15.

Peroxisome proliferator-activated receptor alpha (PPARalpha) and athero-sclerosis.

Gouni-Berthold I, Krone W.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec;5(6):513-23. Review.

PMID:
16503871
16.

Peroxisome proliferator-activated receptors and inflammation.

Moraes LA, Piqueras L, Bishop-Bailey D.

Pharmacol Ther. 2006 Jun;110(3):371-85. Epub 2005 Sep 15. Review.

PMID:
16168490
17.

Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.

Yessoufou A, Wahli W.

Swiss Med Wkly. 2010 Sep 15;140:w13071. doi: 10.4414/smw.2010.13071. Review.

PMID:
20842602
18.
19.

Peroxisome proliferator-activated receptors: from genes to physiology.

Kliewer SA, Xu HE, Lambert MH, Willson TM.

Recent Prog Horm Res. 2001;56:239-63. Review.

PMID:
11237216
20.

The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.

Kliewer SA, Lehmann JM, Milburn MV, Willson TM.

Recent Prog Horm Res. 1999;54:345-67; discussion 367-8. Review.

PMID:
10548883

Supplemental Content

Support Center